Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhenjiang Babu Plaster is a modern hydrogel-based (cataplasm) formulation of the traditional Zhenjiang Plaster, a well-known Traditional Chinese Medicine (TCM) topical treatment. Developed and manufactured by Jiangsu 707 Natural Pharmaceutical Co., Ltd., it is indicated for the relief of pain and inflammation associated with knee osteoarthritis, acute soft tissue injuries, and lumbar disc herniation. The Babu formulation represents a technological advancement over traditional black plasters, utilizing a hydrogel matrix that enhances drug absorption through the skin while minimizing irritation and allergic reactions. Its therapeutic effect is derived from a complex blend of herbal ingredients—including *Angelica sinensis*, *Notopterygium incisum*, and *Rheum palmatum*—which work synergistically to promote blood circulation, disperse blood stasis, and inhibit inflammatory pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zhenjiang Babu Plaster.